FDA Advisory Panel Unanimously Recommends Moderna Booster Shot

Author:
Publish date:
Video Rating:
TV-G
Video Duration:
1

A Food and Drug Administration advisory panel unanimously voted to recommend Moderna  (MRNA) - Get Moderna, Inc. Report COVID booster shots for emergency use in individuals aged 65+ and vulnerable populations.

Moderna took to Twitter  (TWTR) - Get Twitter, Inc. Report and said that it is “grateful” for the decision.

Following a clinical trial of roughly 170 adults, Moderna said half the dosage of its first two shots produced a strong immune response.  

The FDA is expected to issue a final decision in a few days. Once the FDA gives the green light, the Centers for Disease Control and Prevention (CDC) will issue a final recommendation. The Moderna booster shots would be available immediately after the CDC endorsement.

On September 23, the CDC endorsed Pfizer’s  (PFE) - Get Pfizer Inc. Report COVID-19 booster shots for emergency use in individuals aged 65+ and vulnerable populations.

Related: CDC Panel Green Lights Pfizer Booster for Individuals Ages 65+, Vulnerable Population

Related Videos